Lauren Schwimmer
About Lauren Schwimmer
Lauren Schwimmer VP of Preclinical Development
Lauren Schwimmer is the Vice President of Preclinical Development. In this role, she oversees the initial stages of drug development, focusing on the early testing phases before clinical trials. Her responsibilities include managing teams, directing research, and ensuring the quality and efficacy of preclinical trials.
Lauren Schwimmer Education
Lauren Schwimmer holds a Ph.D. in Biochemistry from the Georgia Institute of Technology, which she obtained in 2005. This academic background has provided her with a strong foundation in biochemical principles, critical for her leadership role in preclinical drug development.
Lauren Schwimmer Professional Background
Lauren Schwimmer has a rich professional background. She previously worked at Xoma and Distributed Bio, where she played a crucial role in developing two highly regarded antibody libraries for drug discovery. Her experience includes managing antibody drug discovery and preclinical drug development teams, highlighting her strong leadership and expertise in the field.
Lauren Schwimmer Achievements in Immuno-Oncology
At QLSF, Lauren Schwimmer directed three pre-clinical stage bispecific antibody drug development programs focusing on immuno-oncology. Her work in this area has been instrumental in advancing the development of new cancer therapies.
Lauren Schwimmer Interests
Outside of her professional career, Lauren Schwimmer enjoys dancing, reading, and coaching a Middle School robotics team. These activities reflect her diverse interests and commitment to mentoring the next generation.